Complete financial analysis of Apex Medical Corp. (4106.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Apex Medical Corp., a leading company in the Medical – Devices industry within the Healthcare sector.
- Bristol-Myers Squibb Company (0R1F.L) Income Statement Analysis – Financial Results
- Belpointe REIT, Inc. (BELP) Income Statement Analysis – Financial Results
- Silvaco Group, Inc. Common Stock (SVCO) Income Statement Analysis – Financial Results
- Tarsons Products Limited (TARSONS.BO) Income Statement Analysis – Financial Results
- The Renewables Infrastructure Group Limited (TRIG.L) Income Statement Analysis – Financial Results
Apex Medical Corp. (4106.TW)
About Apex Medical Corp.
Apex Medical Corp. provides medical solutions for healthcare professionals worldwide. The company offers wound management products, including Serene Air and Serene Elite, which are alternating pressure redistribution systems for patients with high to very high risk for pressure ulcers; ACS Turn, a lateral turning mattress for prevention of ventilator-associated pneumonia; Pro-care Optima, an alternating pressure redistribution system for patients with high to very high risk of pressure injuries; Pro-care turn, a bilateral turning air mattress for patients with medium to high risk of pressure injuries; Domus Auto, Domus 4, and Verso for patients with medium to high risk of pressure injury; Domus 3 for patients with medium risk of pressure injury; Domus 2s for patients with low to medium risk of pressure injury; Domus 1 for patients in low risk of pressure injury; Sedens 500 and Sedens 400, which are seat cushions; and Flexi-Air, a non-powered hybrid mattress. It also provides respiratory therapy products, such as nasal masks, full face masks, nasal pillows mask, portable suction unit, and compressor nebulizers; iCH Auto and XT Auto for automatic positive airway pressure; XT Prime, XT Sense, and XT Fit for continuous positive airway pressure; and medical equipment. Apex Medical Corp. was founded in 1990 and is headquartered in New Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.65B | 2.66B | 2.37B | 2.00B | 2.04B | 2.11B | 2.09B | 1.99B | 2.02B | 2.26B | 2.02B | 1.85B | 1.75B | 1.66B | 1.58B |
| Cost of Revenue | 1.51B | 1.60B | 1.39B | 1.16B | 1.18B | 1.23B | 1.18B | 1.11B | 1.11B | 1.22B | 1.17B | 1.10B | 1.11B | 1.03B | 979.35M |
| Gross Profit | 1.14B | 1.07B | 986.95M | 847.63M | 853.82M | 876.87M | 906.52M | 878.18M | 901.17M | 1.05B | 851.00M | 741.52M | 633.64M | 635.68M | 597.92M |
| Gross Profit Ratio | 43.00% | 40.05% | 41.57% | 42.30% | 41.93% | 41.64% | 43.39% | 44.12% | 44.70% | 46.24% | 42.19% | 40.17% | 36.24% | 38.27% | 37.91% |
| Research & Development | 165.76M | 154.28M | 150.75M | 167.83M | 138.19M | 132.16M | 138.93M | 102.93M | 94.50M | 88.56M | 79.88M | 83.89M | 82.51M | 77.23M | 69.97M |
| General & Administrative | 399.37M | 346.90M | 362.97M | 307.53M | 307.27M | 317.45M | 331.29M | 356.00M | 350.05M | 474.49M | 284.15M | 158.79M | 124.51M | 103.04M | 108.10M |
| Selling & Marketing | 379.13M | 379.49M | 369.23M | 275.46M | 273.90M | 290.41M | 284.73M | 259.95M | 246.86M | 258.70M | 304.60M | 259.47M | 211.17M | 230.87M | 178.16M |
| SG&A | 778.50M | 726.38M | 732.20M | 582.99M | 581.16M | 607.87M | 616.01M | 615.95M | 596.91M | 733.18M | 588.75M | 418.25M | 335.68M | 333.90M | 286.26M |
| Other Expenses | 0.00 | 22.52M | 38.57M | 19.03M | 9.42M | 27.35M | 23.56M | 23.05M | 18.60M | 30.08M | 23.86M | 25.24M | 15.59M | 6.37M | 11.54M |
| Operating Expenses | 944.10M | 880.67M | 882.95M | 750.81M | 719.36M | 740.03M | 754.95M | 718.88M | 691.41M | 821.74M | 668.63M | 502.14M | 418.19M | 411.13M | 356.22M |
| Cost & Expenses | 2.45B | 2.48B | 2.27B | 1.91B | 1.90B | 1.97B | 1.94B | 1.83B | 1.81B | 2.04B | 1.83B | 1.61B | 1.53B | 1.44B | 1.34B |
| Interest Income | 6.21M | 2.94M | 2.83M | 2.83M | 4.66M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.31M | 2.34M | 601.00K | 1.40M |
| Interest Expense | 14.18M | 10.18M | 7.67M | 9.28M | 18.00M | 9.69M | 9.36M | 7.87M | 3.72M | 2.90M | 2.67M | 2.49M | 580.00K | 1.18M | 7.63M |
| Depreciation & Amortization | 93.76M | 93.31M | 93.55M | 79.27M | 80.85M | 61.95M | 75.81M | 90.19M | 102.30M | 109.53M | 104.88M | 62.02M | 44.46M | 50.16M | 57.91M |
| EBITDA | 318.12M | 305.21M | 238.98M | 211.28M | 232.97M | 226.14M | 250.94M | 272.54M | 330.65M | 364.40M | 311.45M | 319.75M | 285.84M | 240.85M | 309.27M |
| EBITDA Ratio | 12.02% | 11.46% | 10.07% | 10.54% | 11.44% | 10.54% | 11.34% | 13.07% | 16.40% | 16.10% | 15.42% | 17.83% | 17.92% | 16.45% | 20.50% |
| Operating Income | 194.22M | 211.90M | 145.44M | 132.01M | 152.12M | 136.84M | 151.58M | 159.30M | 209.75M | 224.80M | 182.37M | 239.38M | 215.45M | 224.55M | 241.70M |
| Operating Income Ratio | 7.34% | 7.96% | 6.13% | 6.59% | 7.47% | 6.50% | 7.25% | 8.00% | 10.40% | 9.93% | 9.04% | 12.97% | 12.32% | 13.52% | 15.32% |
| Total Other Income/Expenses | 15.63M | 15.60M | 33.76M | 12.58M | -6.04M | 13.43M | 189.00K | 2.83M | 14.88M | 27.18M | 21.19M | 25.08M | 25.36M | -2.63M | 2.02M |
| Income Before Tax | 209.85M | 200.54M | 138.08M | 124.84M | 128.43M | 150.27M | 151.77M | 162.13M | 224.63M | 251.97M | 203.56M | 264.46M | 269.55M | 221.92M | 257.77M |
| Income Before Tax Ratio | 7.93% | 7.53% | 5.82% | 6.23% | 6.31% | 7.14% | 7.26% | 8.15% | 11.14% | 11.13% | 10.09% | 14.33% | 15.42% | 13.36% | 16.34% |
| Income Tax Expense | 56.84M | 38.42M | 34.57M | 19.47M | 39.62M | 40.95M | 34.08M | 39.44M | 50.70M | 53.87M | 57.33M | 59.36M | 35.65M | 42.48M | 48.69M |
| Net Income | 152.17M | 161.40M | 102.25M | 104.59M | 87.92M | 108.41M | 118.26M | 122.50M | 168.75M | 178.41M | 133.47M | 196.22M | 232.56M | 180.68M | 212.19M |
| Net Income Ratio | 5.75% | 6.06% | 4.31% | 5.22% | 4.32% | 5.15% | 5.66% | 6.16% | 8.37% | 7.88% | 6.62% | 10.63% | 13.30% | 10.88% | 13.45% |
| EPS | 1.51 | 1.60 | 1.01 | 1.04 | 0.87 | 1.17 | 1.42 | 1.47 | 2.02 | 2.14 | 1.60 | 2.25 | 2.79 | 2.17 | 2.55 |
| EPS Diluted | 1.50 | 1.59 | 1.01 | 1.03 | 0.87 | 1.13 | 1.34 | 1.45 | 2.01 | 2.13 | 1.59 | 2.23 | 2.77 | 2.16 | 2.54 |
| Weighted Avg Shares Out | 100.91M | 100.91M | 100.91M | 100.91M | 100.91M | 92.35M | 83.39M | 83.39M | 83.39M | 83.39M | 83.39M | 83.39M | 83.39M | 83.39M | 83.27M |
| Weighted Avg Shares Out (Dil) | 101.57M | 101.54M | 101.32M | 101.33M | 101.30M | 95.91M | 91.71M | 85.37M | 83.87M | 83.73M | 83.72M | 83.90M | 84.08M | 83.78M | 83.80M |
Source: https://incomestatements.info
Category: Stock Reports